Nicollet Investment Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Nicollet Investment Management's RMD Position: Q2 2026 in Review
Nicollet Investment Management increased its ResMed (RMD) stake by 1.3% in Q2 2026, buying an estimated $66.3K and bringing the position to 25,103 shares worth $4.89M. The position accounts for 1.51% of the portfolio, ranked #21.
Nicollet Investment Management first reported a position in RMD in Q1 2024 and has held it in 10 quarters since. The position peaked at $7M in Q3 2025. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Nicollet Investment Management held 25,103 shares of ResMed worth $4.89M as of Q2 2026.
- Nicollet Investment Management bought 320 ResMed shares in Q2 2026, an estimated $66.3K.
- ResMed made up 1.51% of Nicollet Investment Management's portfolio in Q2 2026, its #21 holding.
- Nicollet Investment Management first reported a position in ResMed in Q1 2024 and has held it in 10 quarters since.
- Nicollet Investment Management's ResMed position peaked at $7M in Q3 2025.
- 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Nicollet Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.